Genomic and Molecular Dissection of Hyperdiploid Myeloma
Hyperdiploid myeloma constitutes about 50% of all myeloma making it the most common genetic subtypes of myeloma. Beyond its common association with trisomies and relatively lack of immunoglobulin heavy chain (IgH) translocations, little is known about this subtype of myeloma. In a series of studies we seek to comprehensively study the genetic evolution of hyperdiploid myeloma, it’s molecular phenotype, heterogeneity and their clinical implications. In the process, we have:
We are currently surveying the global genetic changes of H-MM using high resolution array comparative genomic hybridization, trying to establish linkage between the molecular subtypes of H-MM with aCGH defined genomic abnormalities, and validating some of the new therapeutic targets identified. Ultimately, we would like to understand genetic events that initial and mediate transformation from Hyperdiploid MGUS to H-MM.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.